This page is available in multiple languages
Select Language

EnterNext welcomes Crossject on Alternext Paris


Patrick Alexandre, Chairman and Chief Executive Officer of Crossject rings the closing bell.

Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.